TITLE

Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

AUTHOR(S)
Medford, A. R. I.; Millar, A. B.; Medford, A R L
PUB. DATE
July 2006
SOURCE
Thorax;Jul2006, Vol. 61 Issue 7, p621
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury (ALI), remains a devastating condition with a high mortality. It is characterised by alveolar injury and increased pulmonary vascular permeability. Vascular endothelial cell growth factor (VEGF) was identified by its properties to increase permeability and act as a cellular growth factor, hence its potential for a key role in the pathogenesis of ALI/ARDS. This review describes the basic biology of VEGF and its receptors as an essential prerequisite to discussing the available and sometimes paradoxical published data, before considering a paradigm for the role of VEGF in the human lung.
ACCESSION #
21715232

 

Related Articles

  • Molecular Mechanisms in Chronic Obstructive Pulmonary Disease; Potential Targets for Therapy. Willem I. de Boer; Vijay K.T. Alagappan; Hari S. Sharma // Cell Biochemistry & Biophysics;Jan2007, Vol. 47 Issue 1, p131 

    Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease associated with progressiveairflow obstruction. Tobacco smoking is the main risk factor worldwide. In contrast to asthma, antiinflammatorytherapies are rather ineffective in improving chronic symptoms and...

  • Vascular Endothelial Growth Factor.  // Encyclopedic Reference of Molecular Pharmacology;2004, p956 

    A definition of the term "vascular endothelial growth factor" is presented. It refers to a group of at least 4 growth factors VEGF-A, -B, -C and -D. They exert their biological functions as homodimers, and act almost exclusively on endothelial cells.

  • Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease. Hosseini, Reza Farid; Azad, Farahzad Jabbari; Hadis, Yousefzadeh; Rafatpanah, Houshang; Hafizi, Saeed; Tehrani, Homan; Khani, Masoud // Medical Journal of the Islamic Republic of Iran;2014, Vol. 28, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is a third leading cause of death. Methods: In this case control study, we prepared 5 cc bloods from the antecubital vein of 100 COPD patients and 40 healthy individuals as control group. Vascular endothelial growth factor (VEGF)...

  • TIMP-1 in asthma: guilty by association. Johnson, S. R. // Thorax;Aug2005, Vol. 60 Issue 8, p617 

    Focuses on the role of matrix metalloproteinases (MMP) in asthma. Release and activation of growth and angiogenic factors including trasforming growth factor and vascular endothelial growth factor; Contribution of MMPs to altered matrix turnover, epithelial repair and angiogenesis; Association...

  • Program Evaluation Form.  // Ophthalmology Times;6/1/2004 Supplement 5, Vol. 29, p15 

    Presents a program evaluation form from the Dulaney Foundation for a continuing education activity about the role of vascular endothelial growth factor in neovascular age-related macular degeneration. Issuance of a certificate of completion; Options for rating the statements; Extent of program...

  • The role of VEGF in normal and neoplastic hematopoiesis. Gerber, Hans-Peter; Ferrara, Napoleone // Journal of Molecular Medicine;Jan2003, Vol. 81 Issue 1, p20 

    VEGF is a secreted growth factor that mediates its biological effects by binding to two transmembrane tyrosine kinase receptors, VEGFR-1 and VEGFR-2. The VEGF/receptor signaling system is involved in the regulation of two fundamental processes in vertebrates: the formation of blood vessels...

  • Targeting vascular endothelial growth factor: A novel approach in the treatment of cancer. Ignoffo, Robert J. // American Journal of Health-System Pharmacy;11/1/2004, Vol. 61 Issue 21, pS3 

    The article presents information on a symposium conducted on "Targeting Vascular Endothelial Growth Factor: A Novel Approach in the Treatment of Cancer." One of the articles discussed the role of angiogenesis and vascular endothelial growth factor (VEGF), a regulatory factor that stimulates...

  • Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HF-1 α) and the HIF-1 α target gene DEC1, but not lymph node metastasis..... Currie, M J; Hanrahan, V; Gunningham, S P; Morrin, H R; Framplon, C; Han, C; Robinson, B A; Fox, S B // Journal of Clinical Pathology;Aug2004, Vol. 57 Issue 8, p829 

    Background: Vascular endothelial growth factor D (VEGF-D) induces angiogenesis and lymphangiogenesis. Nodal metastasis is recognised as a powerful prognostic marker in breast carcinoma, but the molecular mechanisms underlying this process are unknown. Although it has been suggested that VEGF-D...

  • Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. Pilatova, Katerina; Greplova, Kristina; Demlova, Regina; Bencsikova, Beatrix; Lakka Klement, Giannoula; Zdrazilova-Dubska, Lenka // Journal of Hematology & Oncology;2013, Vol. 6 Issue 1, p1 

    With the recent addition of anti-angiogenic agents to cancer treatment, the angiogenesis regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective tissue activating peptide III (CTAP-III) are two platelet-associated chemokines that modulate tumor angiogenesis,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics